- +1-315-215-1633
- sales@thebrainyinsights.com
The global sclerotherapy needle market was valued at USD 1.57 Billion in 2022, increasing at a CAGR of 4.90% from 2022 to 2030 and anticipated to reach USD 2.31 Billion by 2030. Asia Pacific is expected to grow the fastest during the forecast period. Further, the increasing number of surgical procedures for hemorrhoids, the growing number of cosmetic surgeries, the increase in dermatological testing using sclerotherapy needles by physicians, and the growing demand for biosimilars & vaccination are also expected to propel the market growth during the forecast period.
A sclerotherapy needle is utilized to inject fluid into the submucosal space to promote the lesion away from the underlying muscularis propria & create a less flat target for resection. The needles are usually made of steel-market stainless steel or plastic and come in various sizes. The sclerotherapy solution forces the vein to scar, causing blood to reroute via healthier veins. Sclerotherapy is a medical procedure utilized to eliminate varicose veins & spider veins. The tumbled vein is reabsorbed into local tissue & eventually fades. Sclerotherapy is a first-line treatment for varicose veins, which can be a sign of chronic venous insufficiency. Sclerotherapy involves injecting a solution (generally a salt solution) directly into the vein. The solution scratches the lining of the blood vessel, forcing it to collapse and stick together and the blood to clot. Several solutions can be utilized for sclerotherapy, including glycerin, saline, and polidocanol.
Get an overview of this study by requesting a free sample
Drivers:
The increasing prevalence of varicose veins: The rising cases of obesity, venous stasis ulcers, phlebitis, and thrombosis propel the market growth. Further, varicose veins are an aspect of the spectrum of chronic venous disorder and contain reticular veins, spider telangiectasias, and true varicosities. The high prevalence of varicose veins and their complications is an emerging problem in the 21 st century. Varicose veins are visible, dilated, and twisted venous that can occur in any part of the body where venous returns to the heart are weak but are usually seen in the lower extremities. Also, a large patient base and growing investments by the market players to develop innovative and effective products are helping to boost the market growth. Moreover, the rising demand for biologics, increasing adoption of prefilled syringes, and prevention of needlestick injuries are also helping to drive the market growth during the forecast period. The rise in the geriatric population and widespread chronic diseases are expected to drive the market. Further, the ageing population in developing counties would increase the number of cases of chronic illness and cardiovascular-related disease.
Restraints:
The alternative drug delivery modes: The lack of a proper sterilization system, low healthcare expenditure, and unfavourable taxation policies hamper the market growth. Further, the lack of appropriate training for autoinjectors and alternative drug delivery modes inhibits market growth during the forecast period. Additionally, the high cost associated with the endotherapy devices and the influence of the COVID-19 pandemic hinder market growth. Also, the lack of information and medical expertise in underdeveloped economies is restraining market growth. Moreover, several side effects associated with intradermal injections include inflammations, shivering, muscle pain, and malaise, which are hampering the market growth.
Opportunities:
The increasing advancements in healthcare facilities: The increasing advancements in healthcare infrastructures such as hospitals, clinics, and operating rooms is the driving factor of the market growth. Further, the increase in the number of investors due to the high demand for biologics development is also helping to boost market growth. Additionally, the rising awareness levels regarding blood donation and untapped potential in emerging is the opportunity factor for market growth. Also, the increasing application of better diagnostic medical technology, the growing expenditure to develop healthcare infrastructure, and the cost-savings with intradermal injections for rabies propel the market growth during the forecast period. Additionally, the increase in the outpatient population seeking interventions to manage hemorrhoids is stimulating the market during the forecast period. Moreover, the increase in the preference for minimally invasive cardiac procedures owing to the advantages, including blood loss & pain and less invasion, will stimulate market growth during the upcoming years.
Regional segmentation analysis:
The regions analyzed for the market include Europe, South America, Asia Pacific, North America, the Middle East, and Africa. North America emerged as the largest market for the global sclerotherapy needle market, with a 49.31% market revenue share in 2022. North America dominates the sclerotherapy needle market due to increased awareness about emergency equipment. Also, the presence of significant market players and the technological advancements in related therapeutic procedures propel market growth in this region. Further, the development of cardiovascular surgical instruments, increased awareness of vascular malformations through advertisement and media, growing awareness regarding diabetes management, and increasing advancement in technology is driving factor of the market growth in this region during the forecast period. Asia Pacific is expected to grow the fastest during the forecast period due to the growing incidence of various diseases. Moreover, the developments in the healthcare systems and infrastructure, the unhealthy food habits of the people, and the increasing prevalence of cardiac diseases like heart stroke are propelling the market growth in this region. Additionally, the increase in the acceptance of advanced hemorrhoids surgical devices, growing awareness of the advantages of intradermal injections, increased healthcare, rising R&D expenditure, and the presence of skilled professionals are also helping to drive the market growth in this region during the forecast period.
North America Region Sclerotherapy Needle Market Share in 2022 - 49.31%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
Type segment analysis
The type segment is divided into intramuscular, intradermal, and subcutaneous. In 2022, the intradermal segment dominated the market with the largest market share of 41.06% and market revenue of 0.64 billion. This growth is attributed to the increasing adoption of aesthetic cosmetic procedures. Also, intradermal injection provides a local & minimal systemic effect. It is generally used for tuberculin skin testing but can also be utilized for allergy testing & local anesthetics. Moreover, the increasing incidence of diseases such as tuberculosis, cancer, and other allergies and the increased healthcare expenditure is also helping to boost the segment's market growth. Further, by 2030, the intramuscular segment will likely dominate the market due to the rise in demand for biosimilars and vaccination. Also, favourable reimbursements, government support, and technological advancements propel the segment's market growth. Apart from this, subcutaneous drug delivery refers to the medication injected into an individual's subcutaneous layer (the layer between the skin and muscle).
Application segment analysis
The application segment is divided into hydroceles, hemorrhoids, malformed lymph vessels, and others. In 2022, the hemorrhoids segment dominated the market with the largest market share of 36.04% and market revenue of 0.56 billion. This growth is attributed to the technological developments in hemorrhoid surgical devices. In addition, lifestyle & dietary changes are the primary conservative therapies for hemorrhoids. Lifestyle modification, including raising fluid intake, reducing fat consumption, weight loss, exercise, and regular exercise, is the mainstay. Also, sclerotherapy involves the injection of a chemical solution into the area around each hemorrhoid. The most commonly used chemicals include quinine, zinc chloride, and polidocanol. Further, by 2030, the malformed lymph vessels segment will likely dominate the market due to rising road accidents. Moreover, vascular malformations often result from abnormal development in blood vessels, lymph vessels, veins, and arteries.
End-user segment analysis
The end-user segment is divided into ambulatory surgical units, clinics, hospitals, and others. In 2022, the hospitals segment dominated the market, accounting for around 32.22% of global revenue. This growth is attributed to the increasing number of surgeries along with the growing awareness about the condition. Further, by 2030, the clinic's segment will likely dominate the market due to the expanding number of outpatient procedures performed in clinics. Also, the ever-increasing demand for advanced therapies, such as personalized medicines, is helping to boost the segment's market growth.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion) |
| Market size value in 2022 | USD 1.57 Billion |
| Market size value in 2030 | USD 2.31 Billion |
| CAGR (2022 to 2030) | 4.90% |
| Historical data | 2019-2020 |
| Base Year | 2021 |
| Forecast | 2022-2030 |
| Segments | Key Segments are type, application, end-user, and regions |
| Regional Segments | The key regions are North America, South America, Europe, Asia Pacific, and Middle East & Africa. |
As per The Brainy Insights, the size of the sclerotherapy needle market was valued at USD 1.57 billion in 2022 to USD 2.31 billion by 2030.
Global sclerotherapy needle market is growing at a CAGR of 4.90% during the forecast period 2022-2030.
North America region emerged as the largest market for the sclerotherapy needle.
Key players are Medline Industries, Inc., TeleMed Systems, Inc., SURGIMEDIK, CONMED Corporation, Cook Medical, Boston Scientific, Shaili Endoscopy, STERIS, Diagmed Healthcare, Kangmei Company, STD Pharmaceutical Products Ltd
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By Application
4.3.3. Market Attractiveness Analysis By End-User
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The increase in the geriatric patient population suffering from vertebrae displacement and spinal stenosis or spondylolisthesis
5.2.2. The surge in spinal surgeries
5.2.3. The rise in the prevalence of various neurological diseases
5.3. Restraints
5.3.1. The alternative drug delivery modes
5.3.2. The absence of a skilled workforce
5.4. Opportunities
5.4.1. The increasing advancements in healthcare facilities
5.4.2. The development of new and innovative products
6. Global Sclerotherapy Needle Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Intramuscular
6.3. Intradermal
6.4. Subcutaneous
7. Global Sclerotherapy Needle Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Hydroceles
7.3. Hemorrhoids
7.4. Malformed Lymph Vessels
7.5. Others
8. Global Sclerotherapy Needle Market Analysis and Forecast, By End-User
8.1. Segment Overview
8.2. Ambulatory Surgical Units
8.3. Clinics
8.4. Hospitals
8.5. Others
9. Global Sclerotherapy Needle Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Sclerotherapy Needle Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Sclerotherapy Needle Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Medline Industries, Inc.
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. TeleMed Systems, Inc.
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. SURGIMEDIK
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. CONMED Corporation
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Cook Medical
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Boston Scientific
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Shaili Endoscopy
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. STERIS
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Diagmed Healthcare
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Kangmei Company
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
11.11. STD Pharmaceutical Products Ltd
11.11.1. Business Overview
11.11.2. Company Snapshot
11.11.3. Company Market Share Analysis
11.11.4. Company Product Portfolio
11.11.5. Recent Developments
11.11.6. SWOT Analysis
11.12. Sugimandi
11.12.1. Business Overview
11.12.2. Company Snapshot
11.12.3. Company Market Share Analysis
11.12.4. Company Product Portfolio
11.12.5. Recent Developments
11.12.6. SWOT Analysis
11.13. Blueneem
11.13.1. Business Overview
11.13.2. Company Snapshot
11.13.3. Company Market Share Analysis
11.13.4. Company Product Portfolio
11.13.5. Recent Developments
11.13.6. SWOT Analysis
List of Table
1. Global Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
2. Global Intramuscular, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
3. Global Intradermal, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
4. Global Subcutaneous, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
5. Global Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
6. Global Hydroceles, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
7. Global Hemorrhoids, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
8. Global Malformed Lymph Vessels, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
9. Global Others, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
10. Global Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
11. Global Ambulatory Surgical Units, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
12. Global Clinics, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
13. Global Hospitals, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
14. Global Others, Sclerotherapy Needle Market, By Region, 2019-2030 (USD Billion)
15. North America Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
16. North America Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
17. North America Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
18. U.S. Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
19. U.S. Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
20. U.S. Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
21. Canada Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
22. Canada Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
23. Canada Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
24. Mexico Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
25. Mexico Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
26. Mexico Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
27. Europe Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
28. Europe Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
29. Europe Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
30. Germany Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
31. Germany Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
32. Germany Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
33. France Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
34. France Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
35. France Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
36. U.K. Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
37. U.K. Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
38. U.K. Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
39. Italy Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
40. Italy Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
41. Italy Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
42. Spain Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
43. Spain Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
44. Spain Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
45. Asia Pacific Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
46. Asia Pacific Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
47. Asia Pacific Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
48. Japan Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
49. Japan Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
50. Japan Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
51. China Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
52. China Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
53. China Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
54. India Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
55. India Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
56. India Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
57. South America Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
58. South America Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
59. South America Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
60. Brazil Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
61. Brazil Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
62. Brazil Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
63. Middle East and Africa Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
64. Middle East and Africa Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
65. Middle East and Africa Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
66. UAE Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
67. UAE Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
68. UAE Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
69. South Africa Sclerotherapy Needle Market, By Type, 2019-2030 (USD Billion)
70. South Africa Sclerotherapy Needle Market, By Application, 2019-2030 (USD Billion)
71. South Africa Sclerotherapy Needle Market, By End-User, 2019-2030 (USD Billion)
List of Figures
1. Global Sclerotherapy Needle Market Segmentation
2. Global Sclerotherapy Needle Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top- Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Sclerotherapy Needle Market Attractiveness Analysis By Type
9. Global Sclerotherapy Needle Market Attractiveness Analysis By Application
10. Global Sclerotherapy Needle Market Attractiveness Analysis By End-User
11. Global Sclerotherapy Needle Market Attractiveness Analysis By Region
12. Global Sclerotherapy Needle Market: Dynamics
13. Global Sclerotherapy Needle Market Share By Type (2022 & 2030)
14. Global Sclerotherapy Needle Market Share By Application (2022 & 2030)
15. Global Sclerotherapy Needle Market Share By End-User (2022 & 2030)
16. Global Sclerotherapy Needle Market Share By Regions (2022 & 2030)
17. Global Sclerotherapy Needle Market Share By Company (2021)
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global sclerotherapy needle based on below mentioned segments:
Global Sclerotherapy Needle Market by Type:
Global Sclerotherapy Needle Market by Application:
Global Sclerotherapy Needle Market by End-User:
Global Sclerotherapy Needle by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
